共 9 条
[1]
Sertraline and fluoxetine: Safe treatments for children and adolescents with epilepsy and depression[J] . M.S. Thomé-Souza,E. Kuczynski,K.D. Valente.Epilepsy and Behavior . 2007 (3)
[2]
European agency approves use of fluoxetine for children and teens
[J].
BRITISH MEDICAL JOURNAL,
2006, 332 (7555)
:1407-1407
[3]
Fluoxetine Treatment for Prevention of Relapse of Depression in Children and Adolescents: A Double-Blind, Placebo-Controlled Study[J] . GRAHAM J. EMSLIE,JOHN H. HEILIGENSTEIN,SHARON L. HOOG,KAREN DINEEN WAGNER,ROBERT L. FINDLING,JAMES T. McCRACKEN,MARY E. NILSSON,JENNIE G. JACOBSON.Journal of the American Academy of Child & Adolescent Psychiatry . 2004 (11)
[4]
Safety and side effect profile of fluoxetine[J] . Wernicke.Expert Opinion on Drug Safety . 2004 (5)
[5]
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data[J] . Craig J Whittington,Tim Kendall,Peter Fonagy,David Cottrell,Andrew Cotgrove,Ellen Boddington.The Lancet . 2004 (9418)
[6]
Fluoxetine for Acute Treatment of Depression in Children and Adolescents: A Placebo-Controlled, Randomized Clinical Trial[J] . GRAHAM J. EMSLIE,JOHN H. HEILIGENSTEIN,KAREN DINEEN WAGNER,SHARON L. HOOG,DANIEL E. ERNEST,EILEEN BROWN,MARY NILSSON,JENNIE G. JACOBSON.Journal of the American Academy of Child & Adolescent Psychiatry . 2002 (10)
[7]
Mood disorders in children and adolescents: psychopharmacological treatment[J] . Graham J Emslie,Taryn L Mayes.Biological Psychiatry . 2001 (12)
[8]
Childhood and Adolescent Depression. BHATIA SK,BHATIA SC. American Family Physician . 2007
[9]
The relevance of pharmacokinetic studies in designing efficacy trials in juvenile major depression. Findling R L,McNamara N K,Stansbrey R J,et al. Journal of Child and Adolescent Psychopharmacology . 2006